Triazavirin is primarily used as an antiviral medication, particularly effective against a range of RNA viruses. It is commonly applied in the treatment of influenza, including severe and complicated cases, where it helps reduce the duration and severity of symptoms. Additionally, Triazavirin has shown potential in managing other viral infections, such as those caused by coronaviruses, making it a valuable tool during outbreaks of emerging viral diseases. Its mechanism involves inhibiting viral replication, thereby limiting the spread of the virus within the body. The drug is often administered in clinical settings, especially for patients at high risk of complications, and is available in various forms, including capsules and solutions for injection. Research continues to explore its efficacy against other viral pathogens, broadening its therapeutic applications.